Diagnostic imaging may increase risk of testicular cancer
Early and repeated exposures to diagnostic imaging, such as X-rays and CT scans, may increase…
Browsing: GU Cancers
Gemcitabine and daily radiotherapy for bladder preservation in muscle-invasive bladder cancer
Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy for…
Dual checkpoint blockade promising as pre-surgical approach for certain patients with localised bladder cancer
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1)…
Urine-based liquid biopsy test outperforms urine cytology in detecting bladder cancer
Analysis of DNA copy number variants (CNVs) in the cells exfoliated in urine showed better…
Immunotherapy improves survival in advanced bladder cancer patients
Immunotherapy drug avelumab has been shown to significantly improve survival in patients with the most…
Proton pump inhibitors may affect responses to atezolizumab in patients with urothelial cancer
PPIs are commonly used medications for acid reflux, heartburn, and ulcers. Recent evidence indicates that…
International team identifies a new regulatory pathway in bladder cancer
Researchers from Johns Hopkins University, USA, in collaboration with Insilico Medicine announce the publication of…
Antibiotic overuse reduces bladder cancer survival rates
The over prescribing of antibiotics is reducing survival rates in patients with urothelial carcinoma and…
Potency-enhancing drugs linked to decreased risks in men with colorectal cancer
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5…
Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer
In patients with metastatic bladder cancer, a novel combination of biomarkers from baseline tumour tissues…